Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

2.

Year in Review: Chronic Lymphocytic Leukemia

3.

'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link

4.

Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

5.

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot